Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Feb 2026.
- Largest single sale: $7.7M (15,580 shares) of Vertex Pharmaceuticals on Feb 27, 2026. Filing
- Last sale before this period: Nov 8, 2024.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Vertex Pharmaceuticals (VRTX) | CEO & President, Director | Apr 2, 2018 | Mar 3, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Feb 27, 2026, Vertex Pharmaceuticals: sold 40,000 shares for $19.7M, under a disclosed plan. 1 filing: 1
- Feb 24, 2026, Vertex Pharmaceuticals: 4,981 shares withheld by the company for taxes. 1 filing: 1
- Feb 17, 2026, Vertex Pharmaceuticals: 16,326 shares granted; 6,554 shares withheld by the company for taxes. 1 filing: 1
- Feb 13, 2026, Vertex Pharmaceuticals: 13,041 shares withheld by the company for taxes. 1 filing: 1
- Feb 10, 2026, Vertex Pharmaceuticals: 8,297 shares withheld by the company for taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.